Canada Sepsis Diagnostics Market Size & Outlook, 2025-2030

The sepsis diagnostics market in Canada is expected to reach a projected revenue of US$ 114.6 million by 2030. A compound annual growth rate of 8.7% is expected of Canada sepsis diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$69.9
Forecast, 2030 (US$M)
$114.6
CAGR, 2025 - 2030
8.7%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada sepsis diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada sepsis diagnostics market highlights

  • The Canada sepsis diagnostics market generated a revenue of USD 60.3 million in 2022 and is expected to reach USD 114.6 million by 2030.
  • The Canada market is expected to grow at a CAGR of 8.4% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 60.3 million
Market revenue in 2030USD 114.6 million
Growth rate8.4% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Canada accounted for 6.0% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 114.6 million by 2030.

Blood culture media was the largest segment with a revenue share of 38.97% in 2024. Horizon Databook has segmented the Canada sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


The sepsis diagnostics market in Canada is witnessing robust growth, propelled by a combination of demographic trends, technological advancements, and healthcare policy initiatives.

According to Canadian Sepsis Foundation, 1 in 18 deaths is associated with sepsis, making it the 12th largest cause of death. The rate of Hospital-Acquired Infections (HAIs) in Canada is also increasing. This indicated that in 2022–2023, approximately 1 in every 17 hospitalized patients experienced unintended harm during their hospital stay.

Canadian healthcare authorities have been proactive in implementing guidelines and protocols for the early detection & management of sepsis. The Public Health Agency of Canada (PHAC) and other regulatory bodies are increasingly focusing on improving sepsis outcomes through awareness campaigns and education programs aimed at both healthcare professionals and the general public.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website
Immunexpress View profile 11-50 Seattle, Washington, United States, North America http://www.immunexpress.com
Cepheid View profile 1001-5000 Sunnyvale, California, United States, North America http://www.cepheid.com
Luminex View profile 501-1000 Austin, Texas, United States, North America http://www.luminexcorp.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Bruker Corp View profile 9707 40 Manning Road, Billerica, MA, United States, 01821 https://www.bruker.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Koninklijke Philips NV View profile 73712 Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC https://www.philips.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Canada sepsis diagnostics market size, by product, 2018-2030 (US$M)

Canada Sepsis Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Canada sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online